Oryzon Genomics S.A. (ORYZF)
USD 3.03
(-0.66%)
USD 3.03
(-0.66%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 14.19 Million EUR | -9.6% |
| 2022 | 15.69 Million EUR | 47.88% |
| 2021 | 10.61 Million EUR | 11.49% |
| 2020 | 9.52 Million EUR | -7.36% |
| 2019 | 10.27 Million EUR | 0.0% |
| 2018 | - EUR | -100.0% |
| 2017 | 16.76 Thousand EUR | -97.72% |
| 2016 | 735.31 Thousand EUR | -82.71% |
| 2015 | 4.25 Million EUR | -67.58% |
| 2014 | 13.12 Million EUR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | - USD | 0.0% |
| 2024 Q2 | 4.1 Million EUR | 0.0% |
| 2024 Q3 | - EUR | -100.0% |
| 2023 Q3 | - EUR | -100.0% |
| 2023 Q2 | 7482.87 EUR | 0.0% |
| 2023 Q1 | - EUR | -100.0% |
| 2023 FY | - EUR | -100.0% |
| 2023 Q4 | - EUR | 0.0% |
| 2022 Q1 | - EUR | 0.0% |
| 2022 Q2 | - EUR | 0.0% |
| 2022 FY | 15.69 Million EUR | 47.88% |
| 2022 Q3 | - USD | 0.0% |
| 2022 Q4 | 15.69 Thousand EUR | 0.0% |
| 2021 Q2 | - EUR | 0.0% |
| 2021 FY | 10.61 Million EUR | 11.49% |
| 2021 Q3 | - USD | 0.0% |
| 2021 Q1 | - EUR | 0.0% |
| 2021 Q4 | - USD | 0.0% |
| 2020 Q2 | - EUR | 0.0% |
| 2020 FY | 9.52 Million EUR | -7.36% |
| 2020 Q4 | - EUR | 0.0% |
| 2020 Q3 | - EUR | 0.0% |
| 2020 Q1 | - EUR | 0.0% |
| 2019 Q2 | - EUR | 0.0% |
| 2019 Q1 | - EUR | 0.0% |
| 2019 Q4 | - EUR | 0.0% |
| 2019 FY | 10.27 Million EUR | 0.0% |
| 2019 Q3 | - EUR | 0.0% |
| 2018 FY | - EUR | -100.0% |
| 2018 Q2 | - EUR | 0.0% |
| 2018 Q3 | - EUR | 0.0% |
| 2018 Q4 | - EUR | 0.0% |
| 2018 Q1 | - EUR | 0.0% |
| 2017 Q4 | - EUR | 0.0% |
| 2017 Q2 | - EUR | -100.0% |
| 2017 Q1 | 16.76 Thousand EUR | -47.51% |
| 2017 FY | 16.76 Thousand EUR | -97.72% |
| 2017 Q3 | - EUR | 0.0% |
| 2016 Q2 | 175.61 Thousand EUR | -41.77% |
| 2016 FY | 735.31 Thousand EUR | -82.71% |
| 2016 Q1 | 301.6 Thousand EUR | -63.16% |
| 2016 Q4 | 31.93 Thousand EUR | -85.88% |
| 2016 Q3 | 226.16 Thousand EUR | 28.78% |
| 2015 Q3 | 752.41 Thousand EUR | -69.05% |
| 2015 Q4 | 818.68 Thousand EUR | 8.81% |
| 2015 FY | 4.25 Million EUR | -67.58% |
| 2015 Q1 | 251.11 Thousand EUR | 0.0% |
| 2015 Q2 | 2.43 Million EUR | 868.25% |
| 2014 FY | 13.12 Million EUR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| ContraFect Corporation | - USD | -Infinity% |
| Eiger BioPharmaceuticals, Inc. | 15.77 Million USD | 10.026% |
| Nanobac Pharmaceuticals, Incorporated | 17.62 Thousand USD | -80438.063% |
| Institute of Biomedical Research Corp. | - USD | -Infinity% |
| SQZ Biotechnologies Company | 21.47 Million USD | 33.925% |
| Intellipharmaceutics International Inc. | 65.72 Thousand USD | -21491.425% |
| Evofem Biosciences, Inc. | 18.21 Million USD | 22.101% |
| Santhera Pharmaceuticals Holding AG | 122.95 Million USD | 88.458% |
| Propanc Biopharma, Inc. | - USD | -Infinity% |
| Marizyme, Inc. | 645.81 Thousand USD | -2097.49% |
| Genus plc | 668.8 Million USD | 97.878% |
| Pharming Group N.V. | 245.31 Million USD | 94.215% |
| Therapeutic Solutions International, Inc. | 98.99 Thousand USD | -14235.83% |
| CNBX Pharmaceuticals Inc. | 410.16 Thousand USD | -3359.976% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 76.76 Thousand USD | -18388.05% |
| IMV Inc. | - USD | -Infinity% |
| AXIM Biotechnologies, Inc. | 39.51 Thousand USD | -35811.767% |
| ONE Bio Corp. | 52.29 Million USD | 72.863% |
| RVL Pharmaceuticals plc | 49.72 Million USD | 71.458% |
| Neon Bloom, Inc. | - USD | -Infinity% |
| Mosaic ImmunoEngineering Inc. | - USD | -Infinity% |
| Biomind Labs Inc. | - USD | -Infinity% |
| American Oriental Bioengineering, Inc. | 145.09 Million USD | 90.219% |
| Oncotelic Therapeutics, Inc. | 70 Thousand USD | -20173.731% |
| Skye Bioscience, Inc. | - USD | -Infinity% |
| GlobeStar Therapeutics Corporation | - USD | -Infinity% |
| Mesoblast Limited | 5.9 Million USD | -140.454% |
| THC Farmaceuticals, Inc. | - USD | -Infinity% |
| Arch Therapeutics, Inc. | 75.72 Thousand USD | -18641.234% |
| Acro Biomedical Co., Ltd. | 658.5 Thousand USD | -2055.142% |
| Curative Biotechnology, Inc. | - USD | -Infinity% |
| GB Sciences, Inc. | - USD | -Infinity% |
| MultiCell Technologies, Inc. | 49.32 USD | -28774457.989% |
| Alpha Cognition Inc. | - USD | -Infinity% |
| HST Global, Inc. | - USD | -Infinity% |
| CSL Limited | 14.69 Billion USD | 99.903% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| Agentix Corp. | - USD | -Infinity% |
| Halberd Corporation | 999.00 USD | -1420481.782% |
| Enzolytics Inc. | 52.79 Thousand USD | -26780.089% |
| Resverlogix Corp. | - USD | -Infinity% |
| Nuo Therapeutics, Inc. | 608.52 Thousand USD | -2232.133% |
| argenx SE | 1.22 Billion USD | 98.843% |
| Enzon Pharmaceuticals, Inc. | - USD | -Infinity% |
| Emmaus Life Sciences, Inc. | 29.59 Million USD | 52.051% |
| Inhibitor Therapeutics, Inc. | - USD | -Infinity% |
| Bioxytran, Inc. | - USD | -Infinity% |
| Zenith Capital Corp. | - USD | -Infinity% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | - USD | -Infinity% |
| WPD Pharmaceuticals Inc. | - USD | -Infinity% |
| Cotinga Pharmaceuticals Inc. | - USD | -Infinity% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Adynxx, Inc. | - USD | -Infinity% |
| Genscript Biotech Corporation | 839.52 Million USD | 98.31% |
| Kadimastem Ltd | - USD | -Infinity% |
| Helix BioMedix, Inc. | 997.72 Thousand USD | -1322.396% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Provectus Biopharmaceuticals, Inc. | 557.71 Thousand USD | -2444.622% |
| Capstone Therapeutics Corp. | 48.35 Million USD | 70.651% |
| VioQuest Pharmaceuticals, Inc. | - USD | -Infinity% |
| PsyBio Therapeutics Corp. | - USD | -Infinity% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Accustem Sciences Inc. | - USD | -Infinity% |
| EV Biologics, Inc. | 48.9 Thousand USD | -28921.701% |
| Reve Technologies, Inc. | - USD | -Infinity% |
| Q BioMed Inc. | 284.35 Thousand USD | -4890.861% |
| LadRx Corporation | - USD | -Infinity% |
| Cell Source, Inc. | - USD | -Infinity% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| ProtoKinetix, Incorporated | - USD | -Infinity% |
| Regen BioPharma, Inc. | 236.56 Thousand USD | -5899.16% |
| MetaStat, Inc. | - USD | -Infinity% |
| Northwest Biotherapeutics, Inc. | 1.93 Million USD | -634.555% |
| Itoco Inc. | - USD | -Infinity% |
| Rasna Therapeutics, Inc. | - USD | -Infinity% |
| Wesana Health Holdings Inc. | - USD | -Infinity% |
| Endonovo Therapeutics, Inc. | 140.24 Thousand USD | -10019.374% |
| Pathfinder Cell Therapy, Inc. | - USD | -Infinity% |
| RespireRx Pharmaceuticals Inc. | - USD | -Infinity% |
| GeneThera, Inc. | - USD | -Infinity% |
| AVAX Technologies, Inc. | 617.38 Thousand USD | -2198.669% |
| Ember Therapeutics, Inc. | - USD | -Infinity% |
| NovAccess Global Inc. | - USD | -Infinity% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | - USD | -Infinity% |
| BioStem Technologies, Inc. | 16.68 Million USD | 14.946% |
| NanoSphere Health Sciences Inc. | - USD | -Infinity% |
| Burzynski Research Institute, Inc. | - USD | -Infinity% |
| Qrons Inc. | - USD | -Infinity% |
| Alseres Pharmaceuticals, Inc. | 473.73 Thousand USD | -2895.717% |
| SYBLEU INC | 11.69 Thousand USD | -121237.312% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | - USD | -Infinity% |
| Rebus Holdings, Inc. | - USD | -Infinity% |
| Regen BioPharma, Inc. | 236.56 Thousand USD | -5899.16% |
| ImmunoCellular Therapeutics, Ltd. | - USD | -Infinity% |
| Affymax, Inc. | 1.36 Million USD | -936.641% |
| Mobile Lads Corp. | - USD | -Infinity% |
| International Stem Cell Corporation | 7.78 Million USD | -82.201% |
| CytoDyn Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | - USD | -Infinity% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | - USD | -Infinity% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 13 Thousand USD | -109066.246% |
| Adhera Therapeutics, Inc. | - USD | -Infinity% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | - USD | -Infinity% |
| Innovation Pharmaceuticals Inc. | - USD | -Infinity% |
| Neutra Corp. | 39.53 Thousand USD | -35797.233% |
| Windtree Therapeutics, Inc. | - USD | -Infinity% |
| PureTech Health plc | 3.33 Million USD | -326.175% |
| Coeptis Therapeutics, Inc. | - USD | -Infinity% |
| IXICO plc | 6.66 Million USD | -112.927% |
| IntelGenx Technologies Corp. | 1.03 Million USD | -1265.891% |
| Gelesis Holdings, Inc. | 25.76 Million USD | 44.923% |
| CSL Limited | 14.8 Billion USD | 99.904% |
| Cellectis S.A. | 755 Thousand USD | -1779.684% |